Voyager Therapeutics (VYGR) PT Raised to $36 at Wedbush
- Wall Street rally fizzles out as Evergrande worries persist; Nike drops
- Over $100 Billion Wiped Off: Bitcoin (BTC) Price Falls As China's Central Bank Vows to Ban Cryptocurrency Trading
- Nike (NKE) Stock Falls On a Revenue Miss and Slashed FY Sales Outlook, Analysts Bullish Despite NT Supply Chain Challenges
- Oil heads for third straight week of gains as supply tightens
- Here's Why Meredith (MDP) Stock Price Soared 18% in After Hours
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Wedbush analyst David Nierengarten raised the price target on Voyager Therapeutics (NASDAQ: VYGR) to $36.00 (from $27.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Scientific Games (SGMS) PT Raised to $105 at Craig-Hallum But Has $190+ Upside Potential on Lottery Divestiture
- JBS SA (JBSS3:BZ) (JBSAY) PT Raised to R$54 at Morgan Stanley
- Rockhopper Exploration Plc. (RKH:LN) (RCKHF) PT Lowered to GBP0.10 at Canaccord Genuity
Create E-mail Alert Related CategoriesAnalyst PT Change
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!